Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,380,942
-
Share change
-
+2,380,942
-
Total reported value
-
$34,070,158
-
Price per share
-
$14.31
-
Number of holders
-
21
-
Value change
-
+$34,070,135
-
Number of buys
-
21
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q3 2015
As of 30 Sep 2015,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,380,942 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, LLC, FEDERATED INVESTORS INC /PA/, Cormorant Asset Management, LLC, HIGHLAND CAPITAL MANAGEMENT LP, EMERALD ADVISERS INC/PA, BlackRock Fund Advisors, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
21
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.